Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CK0801 in Aplastic Anemia
NCT07499102Phase 2Not yet recruiting
- Start
- Dec 2026
- Primary completion
- Aug 2028
- Modality
- Regulatory T Cells (Tregs)
01
Overview
A Phase 2 trial of CK0801 in aplastic anemia. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
CK0801
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on NCT07499102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07499102.